2m 2m 2m 2m 2m 2m 2m
IMMIX BIOPHARMA (IMMX)
NASDAQ
$13.58-$0.08 (-0.56%)
Price as of Aug 21, 2026 7:55 PM EDT- $972.5MMarket Cap
- 523.74%1-Year Change
- BiotechnologyIndustry
IMMIX BIOPHARMA (IMMX)
$13.58-$0.08 (-0.56%)
IMMX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.66 | ||
Change | +$0.50 (+3.80%) | ||
Open | $13.36 | ||
High | $13.76 | ||
Low | $13.12 | ||
Previous Close | $13.16 | ||
Volume | 1,510,572 | ||
30-Day Average Volume | 1,557,737 | ||
1-Week Change | 24.52% | ||
1-Month Change | 42.74% | ||
1-Year Change | 523.74% | ||
3-Year Change | 593.40% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 71.2M | ||
Total Assets | $239.1M | ||
Market Cap | $972.5M | ||
Enterprise Value | $747.0M | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$11.5M | ||
Free Cash Flow | -$11.8M | ||
EBIT | -$11.5M | ||
EBITDA | -$11.4M | ||
Net Working Capital | $224.5M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -65 | ||
Enterprise Value/Revenue | 37 | ||
P/B | 4 | ||
P/E | -76 | ||
PEG | N/A | ||
Price/Free Cash Flow | -83 | ||
Price/Operating Cash Flow | -83 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue